Press release
Rising Incidences Of Cancer In Drugs For Immunotherapy Market: A Significant Driver Propelling The Drugs for Immunotherapy Market In 2025
Drugs for Immunotherapy
What Is the Drugs for Immunotherapy Market Size and Projected Growth Rate?
The market for drugs used in immunotherapy has grown rapidly, from $255.14 billion in 2024 to $281.43 billion in 2025 at a CAGR of 10.3%. The growth is driven by the rising incidence of cancer, unmet medical needs, increasing awareness of cancer immunotherapy, higher adoption rates of immunotherapeutic treatments, and growing investment by pharmaceutical companies.
The drugs for immunotherapy market is expected to see rapid growth, reaching $445.12 billion by 2029 with a CAGR of 12.1%. Growth will be driven by personalized immunotherapies, expanding clinical trials, and combination treatment strategies. Major trends include next-gen CAR-T therapies, neoantigen vaccine development, and precision-targeted treatments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2559
What Are the Major Segments in the Drugs for Immunotherapy Market?
The drugs for immunotherapy market covered in this report is segmented -
1) By Type: Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types
2) By Therapy Area: Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas
3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Interferons: Interferon Alfa, Interferon Beta, Interferon Gamma
3) By Interleukins: Interleukin-2 (IL-2), Interleukin-6 (IL-6), Interleukin-12 (IL-12)
4) By Vaccines: Preventive Vaccines, Therapeutic Vaccines
5) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
6) By Other Types: Cancer Cell Therapies, Cytokine Therapy, T-Cell Receptor Therapy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2559&type=smp
What Are The Driving Drugs for Immunotherapy Market Evolution?
The market for immunotherapy drugs is driven by the increasing incidence of cancer worldwide. Major causes of cancer include smoking, alcohol consumption, poor diet, and obesity. According to Macmillan Cancer Support in October 2022, the number of cancer patients is projected to rise from 3.5 million in 2025 to 5.3 million by 2040. This increase in cancer cases is expected to drive the demand for immunotherapy drugs.
Which Firms Dominate The Drugs for Immunotherapy Market Segments?
Major companies operating in the drugs for immunotherapy market include F. Hoffmann-La Roche Ltd., Novartis AG, Amgen Inc., AbbVie Inc., Merck & Co. Inc., GlaxoSmithKline plc, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, Johnson & Johnson, UbiVac, Pfizer Inc., Sanofi SA, Bayer AG, Celgene Corporation, Incyte Corporation, Juno Therapeutics Inc., Bluebird bio, Celldex Therapeutics, BeiGene, BioNTech AG, CytomX Therapeutics, Eisai Co. Ltd., Flexus Biosciences Inc., Genscript Biotech Corporation, Gilead Sciences Inc., Harpoon Therapeutics Inc., Heptares Therapeutics Ltd., Ignyta Inc., Immatics Biotechnologies, Jounce Therapeutics Inc.
What Trends Are Driving Growth in The Drugs for Immunotherapy Market?
Companies in the immunotherapy drugs market are focusing on innovating new products like Keytruda (pembrolizumab), a targeted therapy for cancer treatment. For instance, Merck & Co., Inc. launched Keytruda in January 2023, a drug approved by the FDA for treating various types of cancer. Keytruda works with the immune system to help fight cancer cells, and it is also approved as an adjuvant treatment for non-small cell lung cancer (NSCLC), marking a significant advancement in cancer treatment.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Which Is The Largest Region In The Drugs for Immunotherapy Market?
The countries covered in the drugs for immunotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Drugs for Immunotherapy Market?
2. What is the CAGR expected in the Drugs for Immunotherapy Market?
3. What Are the Key Innovations Transforming the Drugs for Immunotherapy Industry?
4. Which Region Is Leading the Drugs for Immunotherapy Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Incidences Of Cancer In Drugs For Immunotherapy Market: A Significant Driver Propelling The Drugs for Immunotherapy Market In 2025 here
News-ID: 4056905 • Views: …
More Releases from The Business Research Company
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a…
The Increasing Research And Development Investment Is Fueling The Growth Of The …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Analytical Balances And Scales Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for analytical balances and scales has consistently expanded in the past years. The market value, which sat at $0.77 billion in 2024, is predicted to rise to $0.81 billion in 2025,…
Soaring Demand Set to Propel Robot Charging Station Market to $13.31 Billion by …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Robot Charging Station Market Through 2025?
The market size for robotic charging stations has seen speedy expansion in the past few years. The market, which is projected to rise from a worth of $7.15 billion in 2024 to $8.05 billion in 2025,…
Pack Conveyors Market Growth Accelerates: Strategic Forecast Predicts $11.55 Bil …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Pack Conveyors Industry Market Size Be by 2025?
In recent years, there has been a consistent rise in the pack conveyors market size. It's projected to expand from $8.81 billion in 2024 to $9.23 billion in 2025, maintaining a compound annual growth rate (CAGR) of 4.8%.…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
